Evidence map›Paper›PMID 42818089›Full record

ArticlemedRxiv : the preprint server for health sciences2026

Genomic Landscape of Early-Onset and Familial Latin American Parkinson's Patients.

Emily Waldo, Henry Mauricio Chaparro-Solano, Mariam Isayan, Thiago Peixoto Leal, Felipe Duarte-Zambrano, Miguel Inca-Martinez, Janvi Ramchandra, Maria Rivera Paz, Mary B Makarious, Carlos Hernandez and 29 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors.

Emily WaldoGenomic Sciences and Systems Biology, Cleveland Clinic Research, Cleveland Clinic, Cleveland, United States of America.ORCID 0009-0009-1485-3710
Henry Mauricio Chaparro-SolanoGenomic Sciences and Systems Biology, Cleveland Clinic Research, Cleveland Clinic, Cleveland, United States of America.ORCID 0000-0002-1649-7854
Mariam IsayanGenomic Sciences and Systems Biology, Cleveland Clinic Research, Cleveland Clinic, Cleveland, United States of America.ORCID 0009-0002-2387-5347
Thiago Peixoto LealGenomic Sciences and Systems Biology, Cleveland Clinic Research, Cleveland Clinic, Cleveland, United States of America.ORCID 0000-0002-5829-6452
Felipe Duarte-ZambranoGenomic Sciences and Systems Biology, Cleveland Clinic Research, Cleveland Clinic, Cleveland, United States of America.ORCID 0000-0003-2665-1568
Miguel Inca-MartinezGenomic Sciences and Systems Biology, Cleveland Clinic Research, Cleveland Clinic, Cleveland, United States of America.
Janvi RamchandraDepartment of Biomedical Sciences, University of California San Diego, La Jolla, United States of America.ORCID 0009-0002-5473-2146
Maria Rivera PazGenomic Sciences and Systems Biology, Cleveland Clinic Research, Cleveland Clinic, Cleveland, United States of America.ORCID 0000-0003-0862-5673
Mary B MakariousDataTecnica LLC, Washington, DC, United States of America.ORCID 0000-0002-7978-1051
Carlos HernandezFacultad de Medicina Clínica Alemana, Universidad del Desarrollo, Centro de Genética y Genómica, Santiago, Chile.ORCID 0000-0002-6412-3777
Emilia M GattoDepartment of Neurology, Sanatorio de la Trinidad Mitre, Buenos Aires, Argentina.ORCID 0000-0002-1346-5443
Natalia Gonzalez RojasDepartment of Neurology, Sanatorio de la Trinidad Mitre, Buenos Aires, Argentina.
Martin Emiliano CesariniDepartment of Neurology, Sanatorio de la Trinidad Mitre, Buenos Aires, Argentina.
Bruno Lopes Santos-LobatoLaboratório de Neuropatologia Experimental, Universidade Federal do Pará, Belém, Brazil.ORCID 0000-0001-9321-5710
Grace Helena LetroFaculdade de Medicina da Pontifícia, Universidade Católica de Campinas, Campinas, Brazil.ORCID 0000-0002-3815-9514
Jorge Luis OrozcoDepartment of Neurology, Fundacion Valle del Lili, Cali, Colombia.ORCID 0000-0001-6598-1880
Beatriz Munoz OspinaHuman Sciences Department, Universidad Icesi, Cali, Colombia.
Pedro Chana-CuevasCentro de Trastonos del Movimiento, Universidad de Santiago de Chile, Santiago, Chile.ORCID 0000-0001-9946-3299
Natalia Andrea RojasInvestigación, Corporación Centro de Trastornos del Movimiento, Santiago, Chile.
David AguillonGrupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Valentina MullerNeurology Department, Hospital General José de San Martín, Buenos Aires, Argentina.ORCID 0009-0001-5873-0829
Pedro Braga-NetoDepartment of Clinical Medicine, Faculty of Medicine, Federal University of Ceará, Fortaleza, Brazil.ORCID 0000-0001-9186-9243
Mayela Rodríguez-ViolanteLaboratorio Clínico de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.ORCID 0000-0002-6041-9941
Amin Cervantes-ArriagaLaboratorio Clínico de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
Artur F S SchuhDepartment of Pharmacology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.ORCID 0000-0002-8722-0908
Mario Cornejo-OlivasNeurogenetics Working Group, Universidad Cientifica del Sur, Lima, Peru.ORCID 0000-0001-6313-5680
Koni Mejia RojasEDMECON Medical Center, Continuing Medical Education, Lima, Peru.
Cintia ArmasDepartment of Neurodegenerative Diseases and Movement Disorders Unit, Instituto Nacional de Ciencias Neurológicas, Lima, Peru.
Ángel ViñuelaFundación Parkinson Puerto Rico, Guaynabo, Puerto Rico.
Alan Osvaldo Espinal MartinezFundación Parkinson Puerto Rico, Guaynabo, Puerto Rico.
Vitor TumasNeuroscience and Behavior Sciences, Ribeirão Preto Medical School - University of São Paulo, Ribeirão Preto, Brazil.ORCID 0000-0003-2402-2709
Vanderci BorgesDepartment of Neurology and Neurosurgery, Universidade Federal de São Paulo, São Paulo, Brazil.ORCID 0000-0002-8723-2757
Cesar Luis AvilaInstituto de Investigación en Medicina Molecular y Celular Aplicada (IMMCA), UNT-CONICET, San Miguel de Tucumán, Argentina.ORCID 0000-0003-0187-7915
Patricio OlguinNúcleo Intedisciplinario de Biología y Genética, Instituto de Ciencias Biomédicas, Departamento de Neurociencia, Facultad de Medicina, Universidad de Chile, Santiago, Chile.ORCID 0000-0002-8847-4969
Sarael AlcauterInstituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, México.ORCID 0000-0001-8182-6370
Marcelo KauffmanNeurogenetics Unit, Hospital JM Ramos Mejia, Buenos Aires, Argentina.
Dolores Gonzalez-MoronNeurogenetics Unit, Hospital JM Ramos Mejia, Buenos Aires, Argentina.
Susana Lissette PeñaResearch Department, Universidad Andrés Bello, San Salvador, El Salvador.ORCID 0000-0001-8127-6321
Ignacio F MataGenomic Sciences and Systems Biology, Cleveland Clinic Research, Cleveland Clinic, Cleveland, United States of America.ORCID 0000-0003-1198-0633

Funding

Additional Sequencing for the Alzheimer Disease Sequencing Project (ADSP) the Follow-Up Study (FUS), The Global Population InitiativeU01AG076482 · NIA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Clifton L Dalgard, ANTHONY JOHN GRISWOLD · 2022 to 2026
$26.9M
Modeling the impact of Women's Specific Health Factors in PD outcomes in LatinasR01NS112499 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI FERNANDEZ MATA, IGNACIO · 2020 to 2024
$3.3M
Unraveling subcontinental ancestries across Africa, Americas and Europe, and implications for admixture/association mapping of complex traitsR00HG012211 · NHGRI · MOREHOUSE SCHOOL OF MEDICINE · PI Mateus Henrique Gouveia · 2025 to 2026
$498k
BLRD VA I01 BX005978NHGRI NIH HHS R00 HG012211NIA NIH HHS U01 AG076482NINDS NIH HHS R01 NS112499
6 · The paper itself

Abstract

Background: Parkinson's disease (PD), the most common neurodegenerative movement disorder, is commonly thought of as an aging and sporadic disease; however, 5-14% of individuals experience disease onset before the age of 50 years (early-onset PD; EOPD) and about 20% have a positive family history. In the case of both EOPD and people with a family history of PD, evidence suggests higher rates of a disease-causing genetic contribution. Objectives: Our goal was to perform a variant screening of seven PD-related genes and 21 genes associated with related parkinsonian disorders to identify pathogenic/likely pathogenic variants and variants of uncertain significance within EOPD and family-history-positive individuals within the Latin American Research Consortium on the Genetics of PD (LARGE-PD). Methods: We performed short-read whole-genome sequencing on a subset of 263 individuals with EOPD and/or a familial history of PD who had no known pathogenic PD variant in genotyping data. Results: Of the analyzed individuals, a monogenic burden in primary and secondary PD genes due to pathogenic or likely pathogenic variants for PD was observed in 4.7%, an additional 5.5% had pathogenic or likely pathogenic variants for Gaucher's disease, and 2.7% had known risk variants in Conclusions: By expanding the reported spectrum of disease-associated variants in a Latin American population, we identified previously unreported or underrepresented variants that would likely be missed by array-based or targeted screening approaches and contribute to the characterization of EOPD and familial PD in Latin America.

Identifiers

PMID42818089
PMCPMC13622300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.